Bulletin
Investor Alert

New York Markets After Hours

Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204510994/composite

$

95.56

Change

0.00 0.00%

Volume

Volume 16,354

Aug 13, 2020, 4:41 p.m.

Real time quotes

/zigman2/quotes/204510994/composite

Today's close

$ 94.22

$ 95.56

Change

+1.34 +1.42%

Day low

Day high

$94.28

$95.59

Open
Open: 94.59

52 week low

52 week high

$62.48

$110.37

Open

Market cap

$20.61B

Average volume

1.35M

P/E ratio

N/A

Rev. per Employee

$1.38M

EPS

-0.91

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/incy

MarketWatch News on INCY

  1. Incyte stock price target raised to $95 from $79 at Mizuho

    8:23 a.m. Aug. 5, 2020

    - Tomi Kilgore

  2. Lilly Is Testing Its Arthritis Drug as a Coronavirus Treatment

    8:41 a.m. June 15, 2020

    - Barron's Online

  3. Eli Lilly enrolls first patient in phase 3 trial of Olumiant for hospitalized patients with COVID-19

    6:49 a.m. June 15, 2020

    - Tomi Kilgore

  4. Eli Lilly's Olumiant is approved in 70 countries to treat rheumatoid arthritis

    6:50 a.m. June 15, 2020

    - Tomi Kilgore

  5. Incyte downgraded to neutral from overweight at J.P. Morgan

    6:48 a.m. May 6, 2020

    - Tomi Kilgore

  6. Activision Blizzard’s Play for a Pandemic Premium

    6:19 a.m. May 2, 2020

    - Barron's Online

  7. Incyte, Novartis launch drug study to treat coronavirus complication

    4:49 p.m. April 17, 2020

    - Wallace Witkowski

  8. A Blood Test That Could Get America Back to Work

    2:47 p.m. April 4, 2020

    - Barron's Online

  9. Loading more headlines...
/news/nonmarketwatch/company/us/incy

Other News on INCY

  1. Acceleron (XLRN) Reports Narrower-Than-Expected Q2 Loss

    10:36 a.m. Aug. 7, 2020

    - Zacks.com

  2. BMO Capital Keeps Their Hold Rating on Incyte (INCY)

    12:01 p.m. Aug. 6, 2020

    - SmarterAnalyst

  3. Morgan Stanley Remains a Hold on Incyte (INCY)

    11:59 a.m. Aug. 6, 2020

    - SmarterAnalyst

  4. Incyte (INCY) Gets a Hold Rating from Mizuho Securities

    9:15 p.m. Aug. 4, 2020

    - SmarterAnalyst

  5. Leerink Partners Keeps a Hold Rating on Incyte (INCY)

    5:40 p.m. Aug. 4, 2020

    - SmarterAnalyst

  6. Incyte (INCY) Q2 Earnings and Revenues Beat Estimates

    8:45 a.m. Aug. 4, 2020

    - Zacks.com

  7. Incyte Q2 2020 Earnings Preview

    1:20 p.m. Aug. 3, 2020

    - Seeking Alpha

  8. Notable earnings before Tuesday's open

    12:47 p.m. Aug. 3, 2020

    - Seeking Alpha

  9. Xencor gets $25M milestone payment from MorphoSys

    2:40 p.m. Aug. 2, 2020

    - Seeking Alpha

  10. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/incy

Press Releases on INCY

  1. Bromodomain Containing Protein 4 Market Analysis by Research Report 2020

    6:11 a.m. Aug. 5, 2020

    - Market Insight Reports

  2. Tuesday's ETF Movers: TAN, BBH

    12:00 p.m. Aug. 4, 2020

    - MarketNewsVideo.com

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.